Johnson & Johnson has asked the Food and Drug Administration to approve its single-shot Covid-19 vaccine for emergency use in the U.S. If approved, J&J's shot would be the third vaccine available for emergency use in the U.S., joining those developed by Pfizer-BioNTech and Moderna. J&J has said its vaccine was 66% effective overall in protecting against Covid. The FDA's Vaccines and Related Biological Products Advisory Committee will meet on Feb. 26 to discuss the application, and authorization could happen as early as this month.
Here are some of the biggest developments Friday:
The U.S. is recording at least 130,400 new Covid-19 cases and at least 3,200 virus-related deaths each day, based on a seven-day average calculated by CNBC using Johns Hopkins University data.
The following data was compiled by Johns Hopkins University:
- Global cases: More than 105.29 million
- Global deaths: At least 2.29 million
- U.S. cases: More than 26.76 million
- U.S. deaths: At least 458,105